Sign Up for a Free Account
  • Updated 04.21.2020
  • Released 05.06.2011
  • Expires For CME 04.21.2023

Azathioprine

Introduction

Historical note and terminology

Azathioprine is a purine analog that is used as an immunosuppressive drug. Azathioprine was first introduced into clinical practice in 1960 and was replaced with cyclosporine in 1978 (03). It is approved for the prevention of rejection in renal homotransplantation and the treatment of autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. Azathioprine has been proposed for the treatment of multiple sclerosis and used in some European countries, but it has not been approved by the Food and Drug Administration for this indication in the United States. Other neurologic disorders where azathioprine has been used include neuromyelitis optica and myasthenia gravis.

Start a MedLink Neurology trial
to unlock 3 free articles.

  • Nearly 3,000 illustrations, 
including video clips of 
neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of 
neurology in 1,200 
comprehensive articles.

Questions or Comment?

MedLink, LLC

10393 San Diego Mission Rd, Suite 120

San Diego, CA 92108-2134

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com